Four monkeys survived the Ebola virus after being injected with a vaccine that included Immunovaccine Inc.'s technology, the tiny Canadian company said on Monday, and the announcement sent its stock soaring.
The Halifax, Nova Scotia-based company said four monkeys received the vaccine and later survived a dose of Ebola virus that normally would have been lethal. Two other animals that did not receive the vaccine died within a week.
Immunovaccine, which had a market capitalization of about 77 million Cnadian dollars as of Friday, is one of a handful of companies involved in testing potential vaccines for the Ebola virus, which has killed nearly 1,500 people in West Africa.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.